Skip to Content
COVID-19 Response and Update

Our Portfolio

We’ve had FDA approved manufacturing operations in India serving the U.S. market since 2008. We’re so proud to now bring a growing portfolio of high-quality medicines in Ophthalmics and Critical Care to our families and neighbors right here in India. And that’s just the beginning. Our teams are hard at work expanding our portfolio as we look to bring you even more critical Specialty medicines in the Oncology area. Review our current portfolio below.